References
- Akhtar M, Shenasa M, Jazayeri M, et al. Wide QRS complex tachycardia: reappraisal of a common clinical problem. Ann Intern Med 1988: 109(11):905–12
- Zipes DP. Genesis of cardiac arrhythmias: electrophysiological considerations. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 3d ed. Philadelphia: Saunders, 1988
- Tchou P, Young P, Mahmud R, et al. Useful clinical criteria for the diagnosis of ventricular tachycardia. Am J Med 1988; 84(1):53–6
- Baerman JM, Morady F, DiCarlo LA Jr, et al. Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history. Ann Emerg Med 1987; 16(1):40–3
- Millar RN. ‘It looks like SVT’: the misuse of intravenous verapamil in broad-complex tachycardia. (Editorial) S Afr Med J 1989: 76(7): 296–7
- Wellens HJ, Bar FW Lie KI. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 1978;64(1):27–33
- Drago F, Turchetta A, Calzolari A, et al. Detection of atrial tachyarrhythmias by transesophageal pacing and recording at rest and during exercise in children with ventricular preexcitation. Am J Cardiol 1992; 69(12): 1098–9
- Slama R, Motte G, Coumel P, et al. Junctional tachycardia with ventricular aberration and retrograde complete block (ventricular pseudotachycardia). Arch Mal Coeur Vaiss 1971; 64(5):691–700
- Antunes E, Brugada J, Steurer G, et al. The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway. Pacing Clin Electrophysiol 1994:17(9): 1515–24
- Reddy GV, Leghari RU. Standard limb lead QRS concordance during wide QRS tachycardia: a new surface ECG sign of ventricular tachycardia. Chest 1987; 92(4):763–5
- Nelson M. Remember the physical examination. (Letter) Ann Emerg Med 1987: 16(12): 1413
- Merrill JJ, DeWeese G, Wharton JM. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Med 1994; 97(1):25–8
- Ben-Sorek ES, Wiesel J. Ventricular fibrillation following adenosine administration: a case report. Arch Intern Med 1993:153(23): 2701–2
- Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. I. Introduction. JAMA 1992; 268(16):2171–83
- Akhtar M, Gilbert CJ, Shenasa M. Effect of lidocaine on atrioventricular response via the accessory pathway in patients with Wolff-Parkinson-White syndrome. Circulation 1981; 63(2):435–41
- Wellens HJ, Braat S, Bragada P, et al. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol 1982:50(5): 1087–9
- Iseri LT, Chung P, Tobis J. Magnesium therapy for intractable ventricular tachyarrhythmias in normomagnesemic patients. West J Med 1983; 138(6):823–8
- Sager PT, Widerhorn J, Petersen R, et al. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Am Heart J 1990: 119(2 Pt 1):308–16
- Kulick DL, Hong R, Ryzen E, et al. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988; 115(2):367–73
- Rasmussen HS, Thomsen PE. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle. Clin Cardiol 1989: 12(2):85–90